Patent details

EP2299984 Title: ORAL FORMULATIONS OF CYTIDINE ANALOGS AND METHODS OF USE THEREOF

Basic Information

Publication number:
EP2299984
PCT Application Number:
US2009002999
Type:
European Patent Granted for LU
Legal Status:
In force
Application number:
EP097469753
PCT Publication Number:
WO2009139888
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
ORAL FORMULATIONS OF CYTIDINE ANALOGS AND METHODS OF USE THEREOF
French Title of Invention:
FORMULATIONS ORALES D'ANALOGUES DE CYTIDINE ET LEURS PROCÉDÉS D'UTILISATION
German Title of Invention:
ORALE FORMULIERUNGEN VON CYTIDIN-ANALOGA UND ANWENDUNGSVERFAHREN DAFÜR
SPC Number:

Dates

Filing date:
14/05/2009
Grant date:
28/11/2018
EP Publication Date:
30/03/2011
PCT Publication Date:
19/11/2009
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
28/11/2018
EP B1 Publication Date:
28/11/2018
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
Expiration date:
14/05/2029
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
01/03/2024
 
 

Name:
Celgene Corporation
Address:
Route 206 & Province Line Road, Princeton, NJ 08543, United States (US)

History of Owners

From:
21/11/2018
To:
01/03/2024

Name:
CELGENE CORPORATION
Address:
86 Morris Avenue, Summit, NJ 07901, United States (US)

Agent

Name:
OFFICE FREYLINGER S.A.
From:
09/01/2019
Address:
Boîte Postale 48, L-8001, STRASSEN, Luxembourg (LU)
To:

Inventor

1

Name:
LAI, Mei
Address:
United States (US)

2

Name:
ETTER, Jeffrey, B.
Address:
United States (US)

3

Name:
BACKSTROM, Jay, Thomas
Address:
United States (US)

Priority

1

Priority Number:
53609 P
Priority Date:
15/05/2008
Priority Country:
United States (US)

2

Priority Number:
201145 P
Priority Date:
05/12/2008
Priority Country:
United States (US)

3

Priority Number:
157875 P
Priority Date:
05/03/2009
Priority Country:
United States (US)

Classification

IPC classification:
A61K 9/20; A61K 9/28; A61K 31/7068;

Publication

Bulletin

Bulletin Heading:
VB2
Bulletin edition number:
2025/03
Publication date:
06/02/2025
Description:
Section J : Applications for patents or supplementary protection certificates having been restored (art. 40 of the law) Patents or supplementary protection certificates having been restored (art. 70 of the law)

European Patent Bulletin

1

Issue number:
201848
Publication date:
28/11/2018
Description:
Grant (B1)

2

Issue number:
201940
Publication date:
02/10/2019
Description:
Opposition procedure started

3

Issue number:
202443
Publication date:
23/10/2024
Description:
Opposition rejected; Patent maintained as granted

4

Issue number:
202414
Publication date:
03/04/2024
Description:
Change of owner's name or address

Annual Fees

Annual Fee Due Date:
02/06/2025
Annual Fee Number:
17
Annual Fee Amount:
246 Euro
Expected Payer:
Last Annual Fee Payment Date:
26/04/2024
Last Annual Fee Paid Number:
16
Last Annual Fee Paid Amount:
230 Euro
Payer:
CPA GLOBAL THE IP PLATFORM
Filing date Document type Number of pages
09/01/2019 Power Of Attorney 1
30/01/2019 Outgoing Correspondence 1